Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Watt

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Human Vaccines|October 14, 2006
Delivering pneumococcal vaccine to a high risk population: the Navajo experienceAndrea L Benin, James P Watt, Katherine L O'Brien, et al.
Lancet (London, England)|September 15, 2009
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesKatherine L O'Brien, Lara J Wolfson, James P Watt, et al.
Sexually Transmitted Diseases|August 23, 2013
Neisseria gonorrhoeae outbreak: unintended consequences of electronic medical records and using an out-of-state laboratory-California, July 2009-February 2010Erin L Murray, Michael C Samuel, Jennifer Brodsky, et al.
Vaccine|February 6, 2023
Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: A registry-linkage studyKristin L Andrejko, Jennifer F Myers, Nozomi Fukui, et al.
Journal of Clinical Microbiology|August 13, 2010
Rapid drug susceptibility testing with a molecular beacon assay is associated with earlier diagnosis and treatment of multidrug-resistant tuberculosis in CaliforniaRitu Banerjee, Jennifer Allen, S-Y Grace Lin, et al.
Lancet (London, England)|September 15, 2009
Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimatesJames P Watt, Lara J Wolfson, Katherine L O'Brien, et al.
The Journal of Infectious Diseases|June 26, 2003
Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adultsAndrea L Benin, Katherine L O'Brien, James P Watt, et al.
The Journal of Pediatrics|June 19, 2013
Impact of Haemophilus influenzae Type b conjugate vaccine in Mongolia: prospective population-based surveillance, 2002-2010Susana Scott, Dorjpurev Altanseseg, Demberelsuren Sodbayer, et al.
Vaccine|December 30, 2022
Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza seasonKristin L Andrejko, Jennifer F Myers, John Openshaw, et al.
American Journal of Epidemiology|August 19, 2007
Risk factors for invasive pneumococcal disease among Navajo adultsJames P Watt, Katherine L O'Brien, Andrea L Benin, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Human Vaccines|October 14, 2006
Delivering pneumococcal vaccine to a high risk population: the Navajo experienceAndrea L Benin, James P Watt, Katherine L O'Brien, et al.
Lancet (London, England)|September 15, 2009
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimatesKatherine L O'Brien, Lara J Wolfson, James P Watt, et al.
Sexually Transmitted Diseases|August 23, 2013
Neisseria gonorrhoeae outbreak: unintended consequences of electronic medical records and using an out-of-state laboratory-California, July 2009-February 2010Erin L Murray, Michael C Samuel, Jennifer Brodsky, et al.
Vaccine|February 6, 2023
Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: A registry-linkage studyKristin L Andrejko, Jennifer F Myers, Nozomi Fukui, et al.
Journal of Clinical Microbiology|August 13, 2010
Rapid drug susceptibility testing with a molecular beacon assay is associated with earlier diagnosis and treatment of multidrug-resistant tuberculosis in CaliforniaRitu Banerjee, Jennifer Allen, S-Y Grace Lin, et al.
Lancet (London, England)|September 15, 2009
Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimatesJames P Watt, Lara J Wolfson, Katherine L O'Brien, et al.
The Journal of Infectious Diseases|June 26, 2003
Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adultsAndrea L Benin, Katherine L O'Brien, James P Watt, et al.
The Journal of Pediatrics|June 19, 2013
Impact of Haemophilus influenzae Type b conjugate vaccine in Mongolia: prospective population-based surveillance, 2002-2010Susana Scott, Dorjpurev Altanseseg, Demberelsuren Sodbayer, et al.
Vaccine|December 30, 2022
Receipt of COVID-19 and seasonal influenza vaccines in California (USA) during the 2021-2022 influenza seasonKristin L Andrejko, Jennifer F Myers, John Openshaw, et al.
American Journal of Epidemiology|August 19, 2007
Risk factors for invasive pneumococcal disease among Navajo adultsJames P Watt, Katherine L O'Brien, Andrea L Benin, et al.
Pageof 5